Biogen Pharmachem Industries Ltd.
BSE: 531752
₹0.34
₹0.00 (0.00%)As on 09-Jun-2026 16:01IST
Market cap
₹38 Cr
Revenue (TTM)
₹2 Cr
P/E Ratio
44.1
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
-0.5 %
-
ROCE
-0.4 %
-
Industry P/E
126.64
-
EV/EBITDA
39.3
-
Debt to Equity
0
-
Book Value
₹1.1
-
EPS
₹0
-
Face value
1
-
Shares outstanding
1,053,036,833
10 Years Aggregate
CFO
₹-2.24 Cr
EBITDA
₹-10.98 Cr
Net Profit
₹-6.35 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biogen Pharmachem
| -37.4 | -4.1 | -31.5 | -54.1 | -13.2 | 10.7 | 4.4 |
|
BSE Finance
| -9.3 | -3.3 | -5.0 | -6.7 | 8.9 | 8.7 | 11.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Biogen Pharmachem
| -41.5 | -18.1 | 69.5 | 34.4 | 177.3 | 4.5 | -8.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Finance
| 15.7 | 8.7 | 17.1 | 11.1 | 14.1 | 0.8 | 18.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Biogen Pharmachem
|
0.3 | 37.9 | 2.1 | 1.0 | 24.6 | 1 | 44.1 | 0.3 |
| 424.8 | 508.7 | 59.3 | 27.8 | 53.2 | 27 | 18.3 | 6.6 | |
| 42.3 | 234.3 | 301.4 | -46.8 | -9.8 | -34.7 | -- | 1.4 | |
| 8,601.6 | 209.9 | 5.9 | 5.1 | 98.3 | 76.8 | 41.2 | 24.9 | |
| 209.1 | 441.6 | 69.9 | 15.3 | 74.6 | 9.3 | 28.9 | 2.6 | |
| 42.3 | 3,058.9 | 11.3 | -0.3 | -11.6 | -0.5 | -- | 21.9 | |
| 125.3 | 623.4 | 0.0 | -0.2 | -- | -0.3 | 57.5 | -- | |
| 884.9 | 840.5 | 232.5 | 22.0 | 13.9 | 15.6 | 38.1 | 4.4 | |
| 43.9 | 109.6 | 6.0 | 0.8 | 19.9 | 11.6 | 8.8 | 1.0 | |
| 53.0 | 137.6 | 0.9 | -0.7 | -79.4 | -4.6 | -- | 9.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Biogen Pharmachem
Sun Techno Overseas Limited does not have significant operations. Previously it was engaged in trading shares, mutual funds, and other investments. The company was formerly known as Wellworth Overseas Limited and changed its name to Sun Techno... Overseas Limited in August 2011. Sun Techno Overseas Limited was incorporated in 1995 and is based in Rajkot, India. Read more
-
Incorporated
1995
-
Chairman
--
-
Managing Director
--
-
Headquarters
Rajkot, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Biogen Pharmachem
What is the current share price of Biogen Pharmachem Industries Ltd Today?
The share price of Biogen Pharmachem Industries Ltd is ₹0.34 (BSE) as of 09-Jun-2026 16:01 IST. Biogen Pharmachem Industries Ltd has given a return of -13.2% in the last 3 years.
What is the current PB & PE ratio of Biogen Pharmachem Industries Ltd?
The P/E ratio of Biogen Pharmachem Industries Ltd is 44.08 times as on 09-Jun-2026, a 65 discount to its peers’ median range of 126.64 times.
The P/B ratio of Biogen Pharmachem Industries Ltd is 0.33 times as on 09-Jun-2026, a 81 discount to its peers’ median range of 1.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.11
|
|
2024
|
35.81
|
1.22
|
|
2023
|
84.29
|
0.71
|
|
2022
|
0.00
|
1.69
|
|
2021
|
0.00
|
0.25
|
What is the 52 Week High and Low of Biogen Pharmachem Industries Ltd?
The 52-week high and low of Biogen Pharmachem Industries Ltd are Rs 0.93 and Rs 0.32 as of 10-Jun-2026.
What is the market cap of Biogen Pharmachem Industries Ltd?
Biogen Pharmachem Industries Ltd has a market capitalisation of ₹ 38 Cr as on 09-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Biogen Pharmachem Industries Ltd?
Before investing in Biogen Pharmachem Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.